Rare and Orphan Diseases

The experience of attending Rare Disease Day at the National Institutes of Health (NIH) exceeded the confines of the definition for rare and instead should be more appropriately defined as extraordinary shares a new Medika author.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

Real-World Evidence Unlocks Consumer Voice to Improve Care

2024 Health Trends: Progress, Challenges, and Opportunities

LATEST

TRENDING

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

Rare – Always Present and Never Forgotten

The Disorder That Makes Monster Faces Out of Everyone You See

Looking for Zebras: Listening to Patients, Healing the Health System

2024 Health Trends: Progress, Challenges, and Opportunities

Real-World Evidence Unlocks Consumer Voice to Improve Care

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Hair Loss: The Hidden Toll of Stress

It’s Time to Reconsider Deadly Munchausen’s Syndrome by Proxy

Invisible Disabilities Need Our Attention and Understanding Like No Others

EDITORS CHOICE

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

The Disorder That Makes Monster Faces Out of Everyone You See

Rare – Always Present and Never Forgotten

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories